These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35552463)

  • 21. Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial.
    Hoft DF; Blazevic A; Selimovic A; Turan A; Tennant J; Abate G; Fulkerson J; Zak DE; Walker R; McClain B; Sadoff J; Scott J; Shepherd B; Ishmukhamedov J; Hokey DA; Dheenadhayalan V; Shankar S; Amon L; Navarro G; Podyminogin R; Aderem A; Barker L; Brennan M; Wallis RS; Gershon AA; Gershon MD; Steinberg S
    EBioMedicine; 2016 May; 7():278-86. PubMed ID: 27322481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal Bacille Calmette-Guérin vaccination and tuberculin skin test reactions at 2- and 6-months: Effects on mortality up to 1 year of age.
    Schaltz-Buchholzer F; Roth A; de Bree LCJ; Biering-Sørensen S; Timmermann CAG; Monteiro I; Aaby P; Benn CS
    Vaccine; 2021 Dec; 39(50):7286-7294. PubMed ID: 34226104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis vaccines: beyond bacille Calmette-Guerin.
    McShane H
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2782-9. PubMed ID: 21893541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.
    Ritz N; Mui M; Balloch A; Curtis N
    Vaccine; 2013 Jun; 31(30):3098-103. PubMed ID: 23583897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial.
    Ritz N; Dutta B; Donath S; Casalaz D; Connell TG; Tebruegge M; Robins-Browne R; Hanekom WA; Britton WJ; Curtis N
    Am J Respir Crit Care Med; 2012 Jan; 185(2):213-22. PubMed ID: 22071384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial.
    Glynn JR; Fielding K; Mzembe T; Sichali L; Banda L; McLean E; Kanjala C; Crampin AC; Ponnighaus JM; Warndorff DK; Fine PEM;
    Lancet Glob Health; 2021 Oct; 9(10):e1451-e1459. PubMed ID: 34534489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with Intradermal Bacillus Calmette-Guérin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus Macaques.
    Tsujimura Y; Shiogama Y; Soma S; Okamura T; Takano J; Urano E; Murakata Y; Kawano A; Yamakawa N; Asaka MN; Matsuo K; Yasutomi Y
    J Immunol; 2020 Dec; 205(11):3023-3036. PubMed ID: 33097574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivated
    Kuczkowska K; Copland A; Øverland L; Mathiesen G; Tran AC; Paul MJ; Eijsink VGH; Reljic R
    Front Immunol; 2019; 10():1588. PubMed ID: 31354727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
    Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
    Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    Guerra-Maupome M; Vang DX; McGill JL
    PLoS One; 2019; 14(2):e0212751. PubMed ID: 30794653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the decline in neonatal mortality in northern Ghana, 1996-2012, associated with the decline in the age of BCG vaccination? An ecological study.
    Welaga P; Debpuur C; Aaby P; Hodgson A; Azongo DK; Benn CS; Oduro AR
    BMJ Open; 2018 Dec; 8(12):e023752. PubMed ID: 30552267
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Radloff J; Heyckendorf J; van der Merwe L; Sanchez Carballo P; Reiling N; Richter E; Lange C; Kalsdorf B
    Front Immunol; 2018; 9():1708. PubMed ID: 30087678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of individual-level factors on Ex vivo mycobacterial growth inhibition: Associations of immune cell phenotype, cytomegalovirus-specific response and sex with immunity following BCG vaccination in humans.
    Prabowo SA; Smith SG; Seifert K; Fletcher HA
    Tuberculosis (Edinb); 2019 Dec; 119():101876. PubMed ID: 31698310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada.
    Cook VJ; Hernández-Garduño E; Kunimoto D; Hershfield ES; Fanning EA; Hoeppner VH; Elwood RK; FitzGerald JM;
    Can Respir J; 2005 Apr; 12(3):134-8. PubMed ID: 15875064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in tuberculosis vaccines.
    Haile M; Källenius G
    Curr Opin Infect Dis; 2005 Jun; 18(3):211-5. PubMed ID: 15864097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
    Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
    Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-specific immunological effects of selected routine childhood immunisations: systematic review.
    Kandasamy R; Voysey M; McQuaid F; de Nie K; Ryan R; Orr O; Uhlig U; Sande C; O'Connor D; Pollard AJ
    BMJ; 2016 Oct; 355():i5225. PubMed ID: 27737830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.